- Home
- ZLAB vs HTGC Comparison
ZLAB vs HTGC Comparison
Compare ZLAB & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HTGC
- Stock Information
- Founded
- ZLAB 2013
- HTGC 2003
- Country
- ZLAB China
- HTGC United States
- Employees
- ZLAB N/A
- HTGC N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HTGC Investment Managers
- Sector
- ZLAB Health Care
- HTGC Finance
- Exchange
- ZLAB Nasdaq
- HTGC Nasdaq
- Market Cap
- ZLAB 3.6B
- HTGC 3.2B
- IPO Year
- ZLAB 2017
- HTGC 2005
- Fundamental
- Price
- ZLAB $33.57
- HTGC $19.35
- Analyst Decision
- ZLAB Buy
- HTGC Buy
- Analyst Count
- ZLAB 5
- HTGC 8
- Target Price
- ZLAB $54.28
- HTGC $20.94
- AVG Volume (30 Days)
- ZLAB 718.8K
- HTGC 933.5K
- Earning Date
- ZLAB 08-07-2025
- HTGC 07-31-2025
- Dividend Yield
- ZLAB N/A
- HTGC 9.73%
- EPS Growth
- ZLAB N/A
- HTGC N/A
- EPS
- ZLAB N/A
- HTGC 1.33
- Revenue
- ZLAB $418,326,000.00
- HTGC $491,549,000.00
- Revenue This Year
- ZLAB $44.07
- HTGC $7.31
- Revenue Next Year
- ZLAB $49.13
- HTGC $9.64
- P/E Ratio
- ZLAB N/A
- HTGC $14.51
- Revenue Growth
- ZLAB 43.72
- HTGC 3.02
- 52 Week Low
- ZLAB $16.01
- HTGC $15.65
- 52 Week High
- ZLAB $44.34
- HTGC $22.04
- Technical
- Relative Strength Index (RSI)
- ZLAB 44.39
- HTGC 78.46
- Support Level
- ZLAB $32.31
- HTGC $18.86
- Resistance Level
- ZLAB $36.53
- HTGC $18.71
- Average True Range (ATR)
- ZLAB 1.11
- HTGC 0.22
- MACD
- ZLAB -0.20
- HTGC 0.09
- Stochastic Oscillator
- ZLAB 27.12
- HTGC 99.30
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.